Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines

Cancer Genetics and Cytogenetics

Volumn 111, Issue 1, 1999, Pages 37-44

  Keck, Catherine L ^a   Zimonjic, Drazen B ^a   Yuan, Bao Zhu ^a   Thorgeirsson, Snorri S ^a   Popescu, Nicholas C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LINE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 6P; CHROMOSOME 8Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 3; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LIVER NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032905155     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00210-6     Document Type: Article

References (53)

1. Croce C.M., Nowell P.C. Molecular basis of B-cell neoplasia. Blood. 65:1985;1-7.
2. Bishop J.M. The molecular genetics of cancer. Science. 235:1987;305-311.
3. Rowley J.D. Molecular cytogenetics. rosetta stone for understanding cancer: twenty-ninth G.H.A. Clowes Memorial Award Lecture Cancer Res. 50:1990;3816-3825.
4. Sandberg A.A. The Chromosomes in Human Cancer and Leukemia. 2nd Ed:1990;Elsevier Science Publishing Co, Inc, New York.
5. Solomon E., Borrow J., Goddard A.D. Chromosome aberrations and cancer. Science. 254:1991;1153-1160.
6. Weinberg R.A. Tumor suppressor genes. Science. 254:1991;1138-1146.
7. Knudson A.G. Antioncogenes and human cancer. Proc Natl Acad Sci USA. 90:1993;10914-10921.
8. Rabbits T.H. Chromosomal translocations in human cancers. Nature. 372:1994;143-149.
9. Mitelman F., Mertens F., Johansson A.B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet. 15:1997;417-474.
10. Bosch F.X., Munoz N. Hepatocellular carcinoma in the world. epidemiologic questions Adv Appl Biotechnol. 13:1991;35-36.
11. Harris C.C. Hepatocellular carcinogenesis. recent advances and speculations Cancer Cells. 2:1990;146-148.
12. Popescu N.C., Zimonjic D.B. Molecular cytogenetic characterization of cancer cell alterations. Cancer Genet Cytogenet. 93:1997;10-22.
13. Zimonjic D.B., Popescu N.C. An improved procedure for chromosome preparations from solid tumors. Cancer Genet Cytogenet. 72:1994;161.
14. Zimonjic D.B., Simpson S., Popescu N.C., DiPaolo J.A. Molecular cytogenetics of human papillomavirus-negative cervical carcinoma cell lines. Cancer Genet Cytogenet. 82:1995;1-8.
15. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
16. Simon D., Munoz S.J., Maddrey W.C., Knowles B.B. Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet. 45:1990;255-260.
17. Bardi G., Johansson B., Pandis N., Heim S., Mandahl N., Andren-Sandberg A., Hagerstrand I., Mitelman F. Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet. 58:1992;191-195.
18. Werner M., Nolte M., Georgii A., Kelmpnauer J. Chromosome 1 abnormalities in hepatocellular carcinoma. Cancer Genet Cytogenet. 66:1993;130.
19. Chen H.L., Chen Y.C., Chen D.S. Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet. 86:1996;102-106.
20. Hamon-Benais C., Ingster O., Terris B., Couturier-Turpin M.H., Bernheim A., Feldmann G. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization. Hepatology. 23:1996;429-435.
21. Kimura H., Kagawa K., Deguchi T., Nakajima T., Kakusui M., Ohkawara T., Katagishi T., Okanoue T., Kashima K., Ashihara T. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe. Cancer. 77:1996;271-277.
22. Lowichik A., Schneider N.R., Tonk V., Ansari M.Q., Timmons C.F. Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics. Cancer Genet Cytogenet. 88:1996;170-174.
23. Zimmermann U., Feneux D., Mathey G., Gayral F., Franco D., Bedossa P. Chromosomal aberrations in hepatocellular carcinomas. relationship with pathological features Hepatology. 26:1997;1492-1498.
24. Simon D., Knowles B.B., Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene. 6:1991;765-770.
25. Simon D., Carr B.I. Integration of hepatitis B virus and alteration of the 1p36 region found in cancerous tissue of primary hepatocellular carcinoma with viral replication evidenced only in noncancerous, cirrhotic tissue. Hepatology. 22:1995;1393-1398.
26. Sargent L., Sanderson N.D., Thorgeirsson S.S. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes. Cancer Res. 56:1996;2137-2142.
27. Sargent LM, Zhou X, Keck CL, Sanderson ND, Zimonjic DB, Popescu NC, Thorgeirsson SS (in press): Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-myc and transforming growth factor alpha in the liver. Amm. J. Pathol.
28. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
29. Fujimoto Y., Hampton L.L., Wirth P.J., Wang N.J., Xie J.P., Thorgeirsson S.S. Alteration of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 54:1994;281-285.
30. Yeh S.H., Chen P.J., Chen H.L., Lai M.Y., Wang C.C., Chen D.S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellualr carcinomas. Cancer Res. 54:1994;4188-4192.
31. Nagai H., Pineau P., Tiollais P., Buendia M.A., Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogen. 14:1997;2927-2933.
32. Yunis J.J. Multiple recurrent genomic rearrangements and fragile sites in human cancer. Somat Cell Mol Genet. 13:1987;392-403.
33. Popescu N.C. Chromosome fragility and instability in human cancer. Crit Rev Oncogenesis. 5:1994;121-140.
34. Kotin M., Siniscalco M., Samulski R., Zhu X., Hunter L., Laughlin C.A., McLaughlin S., Muzyczka N., Rocchi M., Berns K.I. Site-specific integration by adenoassociated virus. Proc Natl Acad Sci USA. 87:1992;2211-2215.
35. Tanaka K., Yanoshita R., Konishi M., Oshimura M., Maeda Y., Mori T., Miyaki M. Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene. 8:1993;2253-2258.
36. Barker P.E., Savelyeva L., Schwab M. Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells. Oncogene. 8:1994;3353-3358.
37. Hainsworth P.J., Raphael K.L., Stillwell R.G., Bennett R.C., Garson O.M. Rearrangement of chromosome 1p in breast cancer correlates with poor prognostic features. Br J Cancer. 66:1992;131-135.
38. Moley J.F., Brother M.B., Fong C., White P.S., Baylin S.B., Nelkin B., Wells S.A., Brodeur G.M. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res. 52:1992;770-774.
39. Harnett P.R., Kearsley J.H., Hayward N.K., Dracopoli N.C., Kefford R.F. Loss of allelic heterozygosity on distal chromosome 1p in Merkel cell carcinoma. Cancer Genet Cytogenet. 54:1991;109-113.
40. Leister I., Weith A., Brüderlein S., Cziepluch C., Daoroong K., Schlag P., Schwab M. Human colorectal cancer. high frequency of deletions at chromosome 1p35 Cancer Res. 50:1990;7232-7235.
41. Brodeur G.M., Sekhon G.S., Goldstein M.N. Chromosomal aberrations in human neuroblastomas. Cancer. 40:1977;2256-2263.
42. Weith A., Martinsson R., Cziepluch C., Brüderlein S., Amler L.C., Berthold F. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosom Cancer. 1:1989;159-166.
43. Laureys G., Speleman F., Opdenakker G., Leroy J. Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromsom Cancer. 2:1990;252-254.
44. Biegel J.A., White P.S., Marshall H.N., Fujimori M., Zackai E.H., Scher C.D., Brodeur G.M., Emanuel B.S. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet. 52:1993;176-182.
45. Vojta P.J., Futreal P.A., Annab L.A., Kato H., Pereira-Smith O.M., Barret C.A. Evidence for two senescence loci on human chromosome 1. Genes Chromosom Cancer. 16:1996;55-63.
46. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Bernheim A., Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosom Cancer. 18:1997;59-65.
47. Nowell P.C., Croce C.M. Chromosomes, genes and cancer. Am J Pathol. 125:1986;7-16.
48. Pandis N., Bardi G., Mitelman F., Heim S. Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosom Cancer. 18:1997;241-245.
49. Ohta M., Inoue H., Cotticelli M.G., Katstury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:1996;587-597.
50. Zimonjic D.B., Druck T., Ohta M., Kastury K., Croce C.M., Popescu N.C., Heubner K. Position of chromosome 3p14.2 fragile site (FRA3B) within the FHIT gene. Cancer Res. 57:1997;1166-1170.
51. Siprashvili Z., Sozzi G., Barnes L.D., McCue P., Robinson A.K., Eryomin V., Sard L., Tagliabue E., Greco A., Fusetti I., Schwartz G., Pierotti M.A., Croce C.M., Huebner K. Replacement of FHIT in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA. 25:1997;13771-13776.
52. Hino O., Shows T.B., Rogler C.E. Hepatitis B virus integration site in hepatocellular carcinoma at 17;18 chromosome translocation. Proc Natl Acad Sci USA. 83:1986;8338-8342.
53. Yuan B., Miller M.J., Keck C., Zimonjic D.B., Thorgeirsson S.S., Popescu N.C. Cloning, characterization and chromosomal localization of a gene frequently deleted in liver cancer (DLC-1) homologous to rat RhoGap. Cancer Res. 58:1998;2196-2199.